Companies / Santa Cruz Biotechnology / LCMT1 (D-10) AC
Santa Cruz Biotechnology

LCMT1 (D-10) AC | Santa Cruz Biotechnology

mouse monoclonal IgG2a; LCMT1 Antibody (D-10) is an IgG2a κ mouse monoclonal LCMT1 antibody that detects LCMT1 of human origin by WB, IP, IF and ELISA. LCMT1 Antibody (D-10) is available as the non-conjugated anti-LCMT1 antibody form, as well as multiple conjugated forms of anti-LCMT1 antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor® conjugates. Protein phosphatase 2A (PP2A) is a Serine/Threonine (Ser/Thr) phosphatase that is thought to be involved in cell growth and proliferation events and may be associated with tumor progression. The activity of PP2A is regulated by a variety of mechanisms, one of which is the reversible methylation by select methyltransferases. LCMT1 (leucine carboxyl methyltransferase 1), also known as LCMT, PPMT1 or CGI-68, is a 334 amino acid member of the methyltransferase superfamily that is involved in the regulation of PP2A. Specifically, LCMT1 catalyzes the methylation of the carboxy group on the C-terminal leucine of the PP2A catalytic subunit (designated PP2Aα). Via its ability to regulate PP2A function, LCMT1 may be critical for normal mitotic progression and overall cell survival. Two isoforms of LCMT1 are expressed due to alternative splicing events.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.